Health and Human Services Secretary Robert F. Kennedy Jr. ordered the Food and Drug Administration on Monday to revise its ...

OKYO Pharma has filed a Fast Track designation application with the Food and Drug Administration (FDA) for urcosimod in the treatment of neuropathic ...

Urcosmid is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor, typically found on immune ...

The Food and Drug Administration has granted Fast Track designation to LTG-001 for the treatment of acute pain.

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the ...

Forward steps are being made in HNSCC, and the first patient with MDS has been treated with iadademstat/azacitidine.

President Trump’s pick to lead the US Food and Drug Administration tells senators he will follow science and common sense ...

The FDA granted orphan drug status to rhenium-186 obisbemeda for treating leptomeningeal metastases in lung cancer.

Enrollment completed in VIRAGE Phase 2b clinical trial of VCN-01 in metastatic pancreatic ductal adenocarcinoma (PDAC); topline data expected ...

The FDA has granted Fast Track designation to PP-01 for the mitigation of cannabis withdrawal symptoms in patients with cannabis use disorder.

The Food and Drug Administration (FDA) has granted Fast Track designation to troculeucel, an autologous natural killer (NK) cell therapy, for the treatment of moderate Alzheimer disease (AD).

Reported positive six-month data from ADVANCED-2 trial of TARA-002 in patients with NMIBC; Announcement of initial data from ...